Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

PCOS negatively affects self-esteem and social functioning in adolescent girls.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Losing weight and taking birth control pills can greatly improve severe male hormone excess in women with PCOS.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Hormone therapy can improve sexual health and quality of life for women 70 and older.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Homeopathic remedies can help manage PCOS symptoms in girls aged 17-21.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

A multidisciplinary approach effectively improves trichotillomania without side effects.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

PCOS can cause unusual symptoms like late puberty and enlarged clitoris, making diagnosis difficult.

The educational program effectively improved knowledge about PCOS among adolescent girls.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

A rare case of Cushing's syndrome and pheochromocytoma requires careful re-evaluation to avoid complications.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.